Sign Up Today and Learn More About SynaptixBio Stock
Invest in or calculate the value of your shares in SynaptixBio or other pre-IPO companies through EquityZen's platform.
SynaptixBio Stock
SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.
About SynaptixBio Stock
Founded
2021
Industries
SynaptixBio Press Mentions
Stay in the know about the latest news on SynaptixBio
Uwe Meya named SynaptixBio CMO
thepharmaletter • May 26, 2024
Young Essex girl who suffered through childhood and can't walk diagnosed with deadly and incurable disease
essexlive • Jan 28, 2024
Aragen launches $30 million biologics manufacturing facility
biopharma-reporter • Dec 25, 2023
All news articles for November 2023
biopharma-reporter • Dec 25, 2023
Oxford company working on drug to treat rare brain disease
bbc • Dec 25, 2023
SynaptixBio Management
Leadership team at SynaptixBio
Founder & Board Member
Bent Jakobsen
CEO, Executive Director and Co-founder
Dan Williams
Join now and verify your accreditation status to gain access to:
- SynaptixBio current valuation
- SynaptixBio stock price
- Available deals in SynaptixBio and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in SynaptixBio stock?
Accredited investors can buy pre-IPO stock in companies like SynaptixBio through EquityZen funds. These investments are made available by existing SynaptixBio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell SynaptixBio stock?
Shareholders can sell their SynaptixBio stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
